Clinical end point acceptance limit [Study As­sess­ment]

posted by PKS – India, 2019-04-05 10:45 (2281 d 12:29 ago) – Posting: # 20125
Views: 5,346

Should I conclude bio-equivalence with the values of [-0.2025, 0.076] in clinical end point study. Can I assume it as within the interval of (-0.20, 0.20)

Edit: Category changed; see also this post #1. Please follow the Forum’s Policy. [Helmut]

Complete thread:

UA Flag
Activity
 Admin contact
23,426 posts in 4,929 threads, 1,682 registered users;
36 visitors (0 registered, 36 guests [including 20 identified bots]).
Forum time: 23:15 CEST (Europe/Vienna)

You can do one of two things; just shut up,
which is something I don’t find easy,
or learn an awful lot very fast,
which is what I tried to do.    Jane Fonda

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5